Dirk founded anteris medical together with Michael in 2014. He is a seasoned team leader of pharmaceutical and medical device development teams gone Entrepreneur.
Dirk has more than 15 years of experience in small and mid-size biotech…
Kymanox acquires EU-based anteris medical GmbH and anteris helvetia AG
Learn more about the acquisition here: PRESS RELEASE
Contact us at kymanox-anteris-inquiries@kymanox.com to learn about our combined service offerings.
We connect the dots –
so you can focus on your business.
We focus our efforts on supporting clients who either lack resources familiar with medical device development or wish to complement their existing resources.
Schedule your free consultation Too much on your plate? Get in touch!Process
Effective project management throughout the entire product lifecycle: keeping projects in time, on budget, and in compliance with ISO 13485 and 21 CFR 820
Combination Products
Medical Devices
In vitro Diagnostics
Medical Devices
In vitro Diagnostics
Development
Commercialization
In Use
Development
Concept
- Structured user centered concept development
- Innovative requirements management - reduced burden of documentation and improved traceability
- Patient preference studies
Design
- Partner network for industrial design, mechanical design, hardware and software design
- Supplier evaluation and audits
Design Control
- Establishment of EU and US compliant development processes and documentation
Risk Management
- Implementation of risk management processes according to ISO 14971
- Moderation of risk management meetings
Human Factors
- Usability engineering and local support for US or EU handling studies
Clinical Development
- Creation of clinical evaluation according to MEDDEV. 2.7.1 by qualified individuals
- Identification and analysis of relevant clinical data
- Clinical Investigations
tachysCP is a
software-product
of anteris medical
software-product
of anteris medical
Requirements and Risk Management for Combination Products
Ready for combination products
Comes with a pre-compiled catalog of requirements and risks specific for combination product development.
Intuitive & Fast
Without any training or setup needed, you will be able to quickly ensure full traceability and create reports for your technical file and design history file.
Complete, Adaptable & Scalable
Covers all documentation necessary to fulfil compliance to standards combined with the flexibility to be adapted to your specific needs.
Meet the team
Thierry Jomini, MBAGeneral Manager anteris helvetia AG
Thierry is the General Manager of anteris helvetia. He has more than 12 years’ experience in injection devices and combination products for various application such as diabetes, Parkinson disease or hormone therapies.
He has a focus…
Dr. Barbara GollobSenior Regulatory Expert Labeling and Combination Products
Barbara has more than 13 years of global pharma labeling experience.
She has a strong focus on biosimilars and combination products, profound regulatory labeling experience in development and maintenance of complex generics,…
Astrid CachemailleSenior Human Factors Engineering Expert, Member of the Human Factors and Ergonomics Society (HFES)
Astrid is a Human Factors Engineering (HFE) expert with 20 years’ experience in start-up, international mid-sized medtech as well as global pharma companies. She has the understanding of the full development process involving HFE in…
Looking for support in Switzerland?
With anteris helvetia we focus our efforts on supporting clients from Switzerland and from outside of EU, who either lack resources familiar with medical device development or wish to complement their existing resources.